CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II, Open (Partially Double-blind), Randomised, Controlled, Multicentre, Primary Vaccination Study to Evaluate the Immunogenicity (Including Immune Memory), Reactogenicity and Safety of Three Different Formulations of the GSK Biologicals' Combined Haemophilus Influenzae Type B-meningococcal Serogroups CY Conjugate Vaccine Given Concomitantly With Infanrix® Penta and Prevenar®, Versus ActHIB® and Meningitec® Given Concomitantly With Infanrix® Penta and Versus ActHIB® Given Concomitantly With Infanrix® Penta and Prevenar® in Infants According to a 2-4-6 Month Schedule.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00127855
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:49.495842+00:00
Published At: 2012-07-23T00:00:00+00:00
Record Updated At: 2018-08-27
Results Posted At: 2012-07-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Haemophilus Influenzae Type b", "Neisseria Meningitidis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-08-27"
protocolSection.identificationModule.nctId: "NCT00127855"
protocolSection.identificationModule.officialTitle: "A Phase II, Open (Partially Double-blind), Randomised, Controlled, Multicentre, Primary Vaccination Study to Evaluate the Immunogenicity (Including Immune Memory), Reactogenicity and Safety of Three Different Formulations of the GSK Biologicals\u0027 Combined Haemophilus Influenzae Type B-meningococcal Serogroups CY Conjugate Vaccine Given Concomitantly With Infanrix\u00ae Penta and Prevenar\u00ae, Versus ActHIB\u00ae and Meningitec\u00ae Given Concomitantly With Infanrix\u00ae Penta and Versus ActHIB\u00ae Given Concomitantly With Infanrix\u00ae Penta and Prevenar\u00ae in Infants According to a 2-4-6 Month Schedule."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2012-07-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.